Feb 13 (Reuters) - Palisade Bio Inc PALI.O :
* PALISADE BIO PROVIDES CORPORATE UPDATE AND REITERATES
GUIDANCE
* STRATEGIC STREAMLINING OF BOARD
* DONALD WILLIAMS HAS BEEN APPOINTED AS COMPANY'S CHAIRMAN
OF
BOARD
* CONTINUES TO ADVANCE PALI-2108 FOR TREATMENT OF
MODERATE-TO-SEVERE ULCERATIVE COLITIS (UC) TOWARD A PHASE 1
CLINICAL STUDY
* DIRECTORS STEPHANIE DIAZ, CRISTINA CSIMMA, PHARMD, MHP,
ROBERT
TRENSCHEL, DO AND JAMES NEAL, CHAIRMAN OF BOARD, RESIGNED FROM
CO'S BOARD
* DIRECTORS STEPHANIE DIAZ, CRISTINA CSIMMA, ROBERT
TRENSCHEL, AND
JAMES NEAL, CHAIRMAN OF BOARD, RESIGNED FROM CO'S BOARD
Source text for Eikon: ID:nGNX1rfgKc
Further company coverage: PALI.O
((Reuters.Briefs@thomsonreuters.com;))